A Pilot Study of PPX in Women With Metastatic Colorectal Cancer

PHASE1CompletedINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

January 31, 2008

Primary Completion Date

September 30, 2008

Study Completion Date

July 31, 2011

Conditions
Advanced Colorectal Cancer
Interventions
DRUG

Paclitaxel Poliglumex

Paclitaxel Poliglumex 175 mg/m2 will be given over ten minutes every 3 weeks.

Trial Locations (1)

90033

University of Southern California (U.S.C.)/ Norris Comprehensive Cancer Center, Los Angeles

Sponsors
All Listed Sponsors
collaborator

CTI BioPharma

INDUSTRY

collaborator

ASCEND Therapeutics

INDUSTRY

lead

University of Southern California

OTHER

NCT00598247 - A Pilot Study of PPX in Women With Metastatic Colorectal Cancer | Biotech Hunter | Biotech Hunter